267 related articles for article (PubMed ID: 23871531)
21. A single-center experience and review of the literature: 64 cases of phyllodes tumors to better understand risk factors and disease management.
Lightner AL; Shurell E; Dawson N; Omidvar Y; Foster N
Am Surg; 2015 Mar; 81(3):309-15. PubMed ID: 25760210
[TBL] [Abstract][Full Text] [Related]
22. Phyllodes tumor of the breast: a clinic-pathologic study of 77 cases in a Hispanic cohort.
Ossa CA; Herazo F; Gil M; Echeverri C; Ángel G; Borrero M; Madrid J; Jaramillo R
Colomb Med (Cali); 2015 Sep; 46(3):104-8. PubMed ID: 26600624
[TBL] [Abstract][Full Text] [Related]
23. Phyllodes tumors of the breast: a retrospective analysis of 57 cases.
Noordman PCW; Klioueva NM; Weimann MN; Borgstein PJ; Vrouenraets BC
Breast Cancer Res Treat; 2020 Jun; 181(2):361-367. PubMed ID: 32277376
[TBL] [Abstract][Full Text] [Related]
24. Long-term outcomes of malignant phyllodes tumors patients: an institutional experience.
Fou A; Schnabel FR; Hamele-Bena D; Wei XJ; Cheng B; El Tamer M; Klein L; Joseph KA
Am J Surg; 2006 Oct; 192(4):492-5. PubMed ID: 16978957
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Molecular and Biological Characteristics of Phyllodes Tumors of the Breast.
Vorotnikov IK; Vysotskaya IV; Denchik DA; Letyagin VP; Davydov MM; Kirsanov VY; Kim EA; Buseva VS
Bull Exp Biol Med; 2020 Oct; 169(6):806-810. PubMed ID: 33098518
[TBL] [Abstract][Full Text] [Related]
26. The role of adjuvant radiotherapy in patients with malignant phyllodes tumor of the breast: a propensity-score matching analysis.
Zhao W; Tian Q; Zhao A; Wang B; Yang J; Wang L; Zhang L; Dong D; Chen L; Yang J
Breast Cancer; 2021 Jan; 28(1):110-118. PubMed ID: 32748225
[TBL] [Abstract][Full Text] [Related]
27. Management of phyllodes breast tumors.
Guillot E; Couturaud B; Reyal F; Curnier A; Ravinet J; Laé M; Bollet M; Pierga JY; Salmon R; Fitoussi A;
Breast J; 2011; 17(2):129-37. PubMed ID: 21251125
[TBL] [Abstract][Full Text] [Related]
28. [Phyllodes tumors of the breast: analysis of 53 patients].
Bouhafa T; Masbah O; Bekkouch I; Afqir S; Mellas N; Ismaili N; Hassouni K; Kebdani T; Jalil A; Benjaafar N; Errihani H; Elgueddari B
Cancer Radiother; 2009 Apr; 13(2):85-91. PubMed ID: 19119040
[TBL] [Abstract][Full Text] [Related]
29. Expression of EMT markers and mode of surgery are prognostic in phyllodes tumors of the breast.
Feng X; Zhao L; Shen H; Liu X; Yang Y; Lv S; Niu Y
Oncotarget; 2017 May; 8(20):33365-33374. PubMed ID: 28380418
[TBL] [Abstract][Full Text] [Related]
30. Cystosarcoma phyllodes. Diagnosis and management.
Rosenfeld JC; DeLaurentis DA; Lerner H
Cancer Clin Trials; 1981; 4(2):187-93. PubMed ID: 6265113
[TBL] [Abstract][Full Text] [Related]
31. Management of non metastatic phyllodes tumors of the breast: review of the literature.
Khosravi-Shahi P
Surg Oncol; 2011 Dec; 20(4):e143-8. PubMed ID: 21609854
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic analysis of benign, borderline and malignant phyllodes tumors of the breast].
Wang H; Wang X; Wang C
Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):923-7. PubMed ID: 26887622
[TBL] [Abstract][Full Text] [Related]
33. Phyllodes tumors of the breast. The treatment results for 340 patients from a single cancer centre.
Mitus JW; Blecharz P; Jakubowicz J; Reinfuss M; Walasek T; Wysocki W
Breast; 2019 Feb; 43():85-90. PubMed ID: 30521986
[TBL] [Abstract][Full Text] [Related]
34. Treatment and outcome of cystosarcoma phyllodes in Brunei: a 13-year experience.
Kok KY; Telesinghe PU; Yapp SK
J R Coll Surg Edinb; 2001 Aug; 46(4):198-201. PubMed ID: 11523709
[TBL] [Abstract][Full Text] [Related]
35. Malignant phyllodes tumors of the breast: A single institution experience.
Liew KW; Siti Zubaidah S; Doreen L
Med J Malaysia; 2018 Oct; 73(5):297-300. PubMed ID: 30350808
[TBL] [Abstract][Full Text] [Related]
36. Progression of Fibroadenoma to Malignant Phyllodes Tumour in a 14-Year Female.
Faridi SH; Siddiqui B; Ahmad SS; Aslam M
J Coll Physicians Surg Pak; 2018 Jan; 28(1):69-71. PubMed ID: 29290198
[TBL] [Abstract][Full Text] [Related]
37. Retrospective analysis of 25 women with malignant cystosarcoma phyllodes--treatment results.
Soumarová R; Seneklová Z; Horová H; Vojkovská H; Horová I; Budíková M; Růzicková J; Jezková B
Arch Gynecol Obstet; 2004 May; 269(4):278-81. PubMed ID: 15205980
[TBL] [Abstract][Full Text] [Related]
38. Risk of Local Recurrence of Benign and Borderline Phyllodes Tumors: A Danish Population-Based Retrospective Study.
Borhani-Khomani K; Talman ML; Kroman N; Tvedskov TF
Ann Surg Oncol; 2016 May; 23(5):1543-8. PubMed ID: 26714948
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic risk factors for the local recurrence of phyllodes tumors of the breast.
Jang JH; Choi MY; Lee SK; Kim S; Kim J; Lee J; Jung SP; Choe JH; Kim JH; Kim JS; Cho EY; Lee JE; Nam SJ; Yang JH
Ann Surg Oncol; 2012 Aug; 19(8):2612-7. PubMed ID: 22476816
[TBL] [Abstract][Full Text] [Related]
40. Radiation therapy for malignant phyllodes tumor of the breast: An analysis of SEER data.
Kim YJ; Kim K
Breast; 2017 Apr; 32():26-32. PubMed ID: 28013032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
